Liggett S B, Bouvier M, Hausdorff W P, O'Dowd B, Caron M G, Lefkowitz R J
Howard Hughes Medical Institute, Department of Medicine (Pulmonary and Cardiology), Duke University Medical Center, Durham, North Carolina 27710.
Mol Pharmacol. 1989 Oct;36(4):641-6.
As with many other receptor-effector systems, the responsiveness of the beta-adrenergic receptor (beta AR)/adenylyl cyclase system undergoes desensitization upon agonist exposure. Phosphorylations of the receptor by the cAMP-dependent protein kinase (protein kinase A) and the beta AR kinase appear to play roles in such desensitization phenomena, but the functional significance of the receptor phosphorylation in intact cells has not been previously assessed. In this study, we constructed and expressed in a mammalian fibroblast line the normal (wild type) human beta 2 AR and mutant forms of the receptor that lack the putative phosphorylation sites for these two protein kinases. The two consensus sequences for phosphorylation by protein kinase A were altered by changing serines 261, 262 and 345, 346 to alanines. In another mutant, the 11 serines and threonines at the carboxy terminus of the protein that constitute the putative beta AR kinase phosphorylation sites were changed to alanines or glycines. The mutated receptors did not differ from the wild type in their affinities for agonists or antagonists or in their ability to mediate agonist stimulation of adenylyl cyclase. Moreover, their levels of expression in the cultured cells were the same. When stimulated with the beta AR agonist isoproterenol, cells bearing either the wild type or mutant receptors generated cAMP at essentially identical rates for the first 2 min. Cells bearing wild type receptors then showed a rapid desensitization characterized by a markedly diminished rate of cAMP production after the first few minutes of stimulation. However, cells bearing either of the mutated forms of the receptor showed much less desensitization and continued to generate cAMP at a rate 3-4 times greater than that observed in cells expressing the wild type receptor. In contrast, intact cell cAMP levels stimulated by prostaglandin E1 and forskolin were not different between cells bearing wild type or mutant beta AR. These results suggest an important physiological role for phosphorylation of the beta AR in regulating rapid agonist-induced desensitization in intact cells.
与许多其他受体 - 效应器系统一样,β - 肾上腺素能受体(βAR)/腺苷酸环化酶系统在激动剂暴露后会发生脱敏。环磷酸腺苷(cAMP)依赖性蛋白激酶(蛋白激酶A)和βAR激酶对受体的磷酸化似乎在这种脱敏现象中起作用,但此前尚未评估完整细胞中受体磷酸化的功能意义。在本研究中,我们构建了正常(野生型)人β2AR并在哺乳动物成纤维细胞系中表达,以及缺乏这两种蛋白激酶假定磷酸化位点的受体突变形式。通过将丝氨酸261、262和345、346替换为丙氨酸,改变了蛋白激酶A磷酸化的两个共有序列。在另一个突变体中,构成假定βAR激酶磷酸化位点的蛋白羧基末端的11个丝氨酸和苏氨酸被替换为丙氨酸或甘氨酸。突变受体在对激动剂或拮抗剂的亲和力或介导激动剂刺激腺苷酸环化酶的能力方面与野生型没有差异。此外,它们在培养细胞中的表达水平相同。用βAR激动剂异丙肾上腺素刺激时,携带野生型或突变受体的细胞在最初2分钟内产生cAMP的速率基本相同。携带野生型受体的细胞随后表现出快速脱敏,其特征是在刺激开始几分钟后cAMP产生速率明显降低。然而,携带任何一种突变形式受体的细胞脱敏程度要小得多,并继续以比表达野生型受体的细胞中观察到的速率大3 - 4倍的速度产生cAMP。相比之下,携带野生型或突变型βAR的细胞中,前列腺素E1和福斯高林刺激的完整细胞cAMP水平没有差异。这些结果表明βAR磷酸化在调节完整细胞中快速激动剂诱导的脱敏方面具有重要的生理作用。